Today Stock Upgrade Analysis

 TopRated
 
  TopRated
 
Follow  Message
 
 
 
TopRatedStocks uncovering top-rated companies. Providing quick insights and recommendations, they help investors discover high-potential stocks based on robust metrics.
 

•  29 Jan 2026
 

•   AMGN  
   
  0.00%
•   AMPX  
   
  0.00%
•   APLS  
   
  0.00%
•   BE  
   
  0.00%
•   BRO  
   
  +0.01%

$CRCL Circle Internet Group leads the pack with an astounding 94.82% upside potential according to the latest analyst forecasts. Mizuho recently upgraded the outlook from Underperform to Neutral, signaling that the worst of the selling pressure may be in the rearview mirror.

$APLS Apellis Pharmaceuticals is showing a projected 56.04% upside following an initiation of coverage by Barclays. While the firm started with an Equal-Weight recommendation, the discrepancy between the current price and the valuation target is catching the eye of growth-focused traders. The market is currently weighing execution risks against the massive addressable market for its geographic atrophy treatments.

$AMPX Amprius Technologies has become a favorite for momentum seekers after Needham initiated coverage with a Buy rating and a forecasted 46.16% upside. The stock reacted with a 13.36% surge on heavy volume, reflecting trader confidence in their silicon anode battery technology.

$INSM Insmed offers a significant 39.76% upside potential as Barclays initiates coverage with an Overweight recommendation. As a biotech firm focused on rare and serious diseases, INSM is gaining institutional visibility that often serves as a catalyst for a re-rating.

$BRO Brown & Brown has seen its outlook improved by Keefe Bruyette & Woods, with analysts forecasting a 30.67% upside. The upgrade from Underperform to Market Perform suggests that the market previous bearishness was overdone.

$COF Capital One Financial is highlighted by Bank of America as a premier value play with a price target of $280, representing approximately 27% upside from its current 219.31 level. The firm is bullish on the Brex acquisition and its impact on the Spark Card portfolio.

$BE Bloom Energy continues to offer a projected 30.25% upside potential despite a mixed reception from analysts. While Barclays is cautious, China Renaissance maintains a Buy rating, highlighting the massive total addressable market in the hydrogen and clean energy sector.

$GM General Motors is seeing its 2026 profit estimates boosted by JPMorgan, with a price target of $100 implying roughly 16% upside. Analysts believe the market is still discounting GM ability to scale EV margins and eliminate production penalties.

$AMGN Amgen remains a high conviction pick with UBS raising its price target to $390, suggesting about 14% upside from recent levels. As a leader in the pharma and biotech space, AMGN provides a rare combination of dividend income and capital appreciation potential.

$GRAB Grab Holdings rounds out the list with a target of $6.20, representing nearly 38% upside potential. HSBC upgraded the stock to Buy, noting that the valuation has become extremely attractive following a period of consolidation.

View All Headlines